0001055726-23-000043.txt : 20230517 0001055726-23-000043.hdr.sgml : 20230517 20230517161239 ACCESSION NUMBER: 0001055726-23-000043 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230515 FILED AS OF DATE: 20230517 DATE AS OF CHANGE: 20230517 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sumner Michael John CENTRAL INDEX KEY: 0001936799 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14888 FILM NUMBER: 23931832 MAIL ADDRESS: STREET 1: 660 W. GERMANTOWN PIKE STREET 2: SUITE 110 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INOVIO PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001055726 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330969592 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6769 MESA RIDGE RD. CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8584103134 MAIL ADDRESS: STREET 1: 6769 MESA RIDGE RD. CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: INOVIO BIOMEDICAL CORP DATE OF NAME CHANGE: 20050404 FORMER COMPANY: FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL CORP DATE OF NAME CHANGE: 20011116 FORMER COMPANY: FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL LTD DATE OF NAME CHANGE: 19980213 4 1 wk-form4_1684354347.xml FORM 4 X0407 4 2023-05-15 0 0001055726 INOVIO PHARMACEUTICALS, INC. INO 0001936799 Sumner Michael John 660 W. GERMANTOWN PIKE SUITE 110 PLYMOUTH MEETING PA 19462 0 1 0 0 Chief Medical Officer 0 Restricted Stock Unit 2023-05-15 4 A 0 85878 0 A Common Stock 85878 85878 D Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 85,878 restricted stock units is as follows: 28,626 shares will vest on May 15, 2024; 28,626 shares will vest on May 15, 2025; and 28,626 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. This grant was made under the 2016 Omnibus Incentive Plan. /s/ Michael John Sumner 2023-05-17